Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bartlmanon Jan 10, 2018 6:04pm
104 Views
Post# 27328552

RE:Today, we hit a multi-year closing low

RE:Today, we hit a multi-year closing low
I agree newday. I haven't been able to resist at these prices and my share tally continues to grow daily. I believe there has been some form of manipulation (even if it is simply the fear factor) at work and, considering the absence of any negative news, I see nothing different about the essentials of TLT from when it was trading in the 40's. What an opportunity to buy before it returns to those levels.

In the meantime, what might Roger be up to? There is nothing slower than a clinical trial and, as I mentioned some time ago, it provides the opportunity for a CEO to be up to all kinds of mischief. Like more trials for an ever expanding array of indidcations. But I believe that one thing that Roger might have his hands full with at the moment is simply the volume of intellectual protective work required by the host of new discoveries being made by his cast and crew. New and more potent PDT's. New methods of delivery. X-Ray activated stuff. The field of oncolytics stands ready to yield to all that is being discovered by TLT and associates. I believe that Roger might well be totally occupied putting an IP blanket over all of these things. At the very least, he should be and this, not an easy task. The entire cancer domainis potentially ours. In the meantime, who can pass up a 22 penny bargain? Not this kid. Thanks to all who daily sell me shares at prices I couldn't believe possible. TLT rules!
Bullboard Posts